P01.031 VXM01 phase I study in patients with progressive glioblastoma - final results

BACKGROUND: VXM01 consists of the attenuated Salmonella Typhi strain Ty21a carrying a plasmid encoding vascular endothelial growth factor receptor 2 (VEGFR2). The bacterium serves as a vector to deliver the plasmid into the Peyer’s patches via the oral route of administration. The vaccine elicits a...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neuro Oncol
Prif Awduron: Wick, W, Wick, A, Sahm, F, Riehl, D, von Deimling, A, Bendszus, M, Mickingereder, P, Beckhove, P, Schmitz Winnenthal, F, Jungk, C, Wieckoswski, S, Keller, A, Podola, L, Herold-Mende, C, Lubenau, H, Unterberg, A, Platten, M J
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2018
Pynciau:
Poster Presentations
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144123/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.073
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg